Page 121 - FINAL PROGRAM
P. 121
WEDNESDAY, 6 JULY 2016
14:00 - 15:15 Room 101
Session 74: PCOS
14:00 O-292
14:15 O-293
14:30 O-294
14:45 O-295
15:00 O-296
Dysregulation of steroids pathways in granulosa cells may contribute to overexpression of anti-Müllerian hormone system in women with polycystic ovary syndrome
R. Chrystele (France)
A novel method to demonstrate that pregnant women with PCOS hyper-expose their fetus to androgens: A possible stepping stone for the developmental theory of PCOS
R. Homburg (United Kingdom)
Prevalence of type 2 diabetes (DM2) at rst presentation among women with polycystic ovarian syndrome (PCOS) and normal ovulatory controls
T.Y.T. Ngan (Canada)
Polycystic ovary syndrome (PCOS), hyperandrogenism and overweight/obesity, independently and interactively, increase the risk of metabolic syndrome
M. Ollila (Finland)
GnRH agonist for triggering nal oocyte maturation in patients with PCO at high risk for severe OHSS: factors predicting live birth in subsequent FRET cycles
T. Tarlatzi (Belgium)
FINAL PROGRAMME I HELSINKI, FINLAND – 3 TO 6 JULY 2016 117
SCIENTIFIC PROGRAMME WEDNESDAY, 6 JULY
